In our last post, we discussed strategic planning and early case assessment (ECA) in complex litigation to maximize success and leveraging advanced technologies like generative AI to facilitate that ...
The revolution in cancer drug development has a caveat: Only a fraction of eligible patients take part in clinical trials. Historically, findings from studies estimate that the share of eligible ...